Add to ORKGSwitching from premixed insulin to glargine-based insulin regimen improves glycaemic control in patients with type 1 or type 2 diabetes: a retrospective primary care-based analysi
Aims To study prospectively the impact of initiating insulin glargine in suboptimally controlled ins...
peer reviewedInitiating or intensifying insulin therapy is often considered as a challenge in genera...
Objective To look at the effect of Glargine on HbA1c values compared to previous insulin regimen of ...
Background: Insulin glargine (glargine) and premixed insulins (premix) are alternative insulin treat...
Background: Insulin glargine (glargine) and insulin NPH (NPH) are two basal insulin treatments. This...
The aim was to observe the effects of switching from neutral protamine Hagedorn (NPH) insulin to ins...
none6BACKGROUND AND AIMS: Glargine improves glucose control and reduces the risk of nocturnal hypogl...
AbstractAimsDemonstrate superiority of insulin glargine (±glulisine) strategy versus premixed insuli...
AIMS: The objective of this study was to evaluate glycemic control in type 1 diabetic mellitus patie...
To investigate the differences in glycemic variability between the long-acting insulins glargine and...
Because of the increasing prevalence of type 2 diabetes, the need to intensify treatment to manage h...
Abstract Background This study aimed to examine the switch from glargine+once daily insulin aspart (...
OBJECTIVE Fixed-ratio combinations of basal insulin plus glucagon-like peptide 1 receptor agonist (G...
Aims: Demonstrate superiority of insulin glargine (+/- glulisine) strategy versus premixed insulin s...
Type 2 diabetes mellitus (T2DM) is a major cause of morbidity and mortality worldwide and is an impo...
Aims To study prospectively the impact of initiating insulin glargine in suboptimally controlled ins...
peer reviewedInitiating or intensifying insulin therapy is often considered as a challenge in genera...
Objective To look at the effect of Glargine on HbA1c values compared to previous insulin regimen of ...
Background: Insulin glargine (glargine) and premixed insulins (premix) are alternative insulin treat...
Background: Insulin glargine (glargine) and insulin NPH (NPH) are two basal insulin treatments. This...
The aim was to observe the effects of switching from neutral protamine Hagedorn (NPH) insulin to ins...
none6BACKGROUND AND AIMS: Glargine improves glucose control and reduces the risk of nocturnal hypogl...
AbstractAimsDemonstrate superiority of insulin glargine (±glulisine) strategy versus premixed insuli...
AIMS: The objective of this study was to evaluate glycemic control in type 1 diabetic mellitus patie...
To investigate the differences in glycemic variability between the long-acting insulins glargine and...
Because of the increasing prevalence of type 2 diabetes, the need to intensify treatment to manage h...
Abstract Background This study aimed to examine the switch from glargine+once daily insulin aspart (...
OBJECTIVE Fixed-ratio combinations of basal insulin plus glucagon-like peptide 1 receptor agonist (G...
Aims: Demonstrate superiority of insulin glargine (+/- glulisine) strategy versus premixed insulin s...
Type 2 diabetes mellitus (T2DM) is a major cause of morbidity and mortality worldwide and is an impo...
Aims To study prospectively the impact of initiating insulin glargine in suboptimally controlled ins...
peer reviewedInitiating or intensifying insulin therapy is often considered as a challenge in genera...
Objective To look at the effect of Glargine on HbA1c values compared to previous insulin regimen of ...